Selenium prevents cognitive decline and oxidative damage in rat model of streptozotocin-induced experimental dementia of Alzheimer's type
- PMID: 19374888
- DOI: 10.1016/j.brainres.2009.04.010
Selenium prevents cognitive decline and oxidative damage in rat model of streptozotocin-induced experimental dementia of Alzheimer's type
Abstract
Selenium (Se), a nutritionally essential trace element with known antioxidant potential, protects the brain from oxidative damage in various models of neurodegeneration. Intracerebroventricular-streptozotocin (ICV-STZ) in rats causes impairment of brain glucose and energy metabolism along with oxidative damage and cholinergic dysfunction, and provides a relevant model for sporadic dementia of Alzheimer's type (SDAT). The present study demonstrates the therapeutic efficacy of Se on cognitive deficits and oxidative damage in ICV-STZ in rats. Male Wistar rats were pre-treated with sodium selenite, a salt of Se (0.1 mg/kg; body weight) for 7 days and then were injected bilaterally with ICV-STZ (3 mg/kg), while sham rats received the same volume of vehicle. After two ICV-STZ infusions, rats were tested for memory deficits in passive avoidance and Morris water maze (MWM) tests and then were sacrificed for biochemical and histopathological assays. ICV-STZ-infused rats showed significant loss in learning and memory ability, which were significantly improved by Se supplementation. A significant increase in thio-barbituric acid reactive species (TBARS), protein carbonyl (PC) and a significant decrease in reduced glutathione (GSH), antioxidant enzymes (glutathione peroxidase [GPx] and glutathione reductase [GR]) and adenosine triphosphate (ATP) in the hippocampus and cerebral cortex and choline acetyltransferase (ChAT) in hippocampus were observed in ICV-STZ rats. Se supplementation significantly ameliorated all alterations induced by ICV-STZ in rats. Our study reveals that Se, as a powerful antioxidant, prevents cognitive deficits, oxidative damage and morphological changes in the ICV-STZ rats. Thus, it may have a therapeutic value for the treatment of SDAT.
Similar articles
-
Coenzyme Q10 modulates cognitive impairment against intracerebroventricular injection of streptozotocin in rats.Behav Brain Res. 2006 Jul 15;171(1):9-16. doi: 10.1016/j.bbr.2006.03.009. Epub 2006 Apr 18. Behav Brain Res. 2006. PMID: 16621054
-
Amelioration of cognitive deficits and neurodegeneration by curcumin in rat model of sporadic dementia of Alzheimer's type (SDAT).Eur Neuropsychopharmacol. 2009 Sep;19(9):636-47. doi: 10.1016/j.euroneuro.2009.02.002. Epub 2009 Mar 28. Eur Neuropsychopharmacol. 2009. PMID: 19329286
-
Effects of Pycnogenol and vitamin E on cognitive deficits and oxidative damage induced by intracerebroventricular streptozotocin in rats.Behav Pharmacol. 2009 Oct;20(7):567-75. doi: 10.1097/FBP.0b013e32832c7125. Behav Pharmacol. 2009. PMID: 19654508
-
Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease.Adv Drug Deliv Rev. 2008 Oct-Nov;60(13-14):1463-70. doi: 10.1016/j.addr.2008.04.015. Epub 2008 Jul 4. Adv Drug Deliv Rev. 2008. PMID: 18655815 Review.
-
Lipoic acid as a novel treatment for Alzheimer's disease and related dementias.Pharmacol Ther. 2007 Jan;113(1):154-64. doi: 10.1016/j.pharmthera.2006.07.001. Epub 2006 Sep 20. Pharmacol Ther. 2007. PMID: 16989905 Review.
Cited by
-
The Role of Gut Microbiota in the Neuroprotective Effects of Selenium in Alzheimer's Disease.Mol Neurobiol. 2024 Jul 16. doi: 10.1007/s12035-024-04343-w. Online ahead of print. Mol Neurobiol. 2024. PMID: 39012446 Review.
-
Nootropic effect of Indian Royal Jelly against okadaic acid induced rat model of Alzheimer's disease: Inhibition of neuroinflammation and acetylcholineesterase.J Tradit Complement Med. 2023 Nov 15;14(3):300-311. doi: 10.1016/j.jtcme.2023.11.005. eCollection 2024 May. J Tradit Complement Med. 2023. PMID: 38707922 Free PMC article.
-
Neuroprotective mechanism of trans,trans-Farnesol in an ICV-STZ-induced rat model of Alzheimer's pathology.Inflammopharmacology. 2024 Apr;32(2):1545-1573. doi: 10.1007/s10787-023-01413-8. Epub 2024 Feb 3. Inflammopharmacology. 2024. PMID: 38308793
-
Enhanced Neuroprotective Synergy of Atorvastatin and Magnesium L-Threonate in a Rat Model of Alzheimer's Disease Induced by Aluminum Chloride.Cureus. 2023 Nov 6;15(11):e48400. doi: 10.7759/cureus.48400. eCollection 2023 Nov. Cureus. 2023. PMID: 38074017 Free PMC article.
-
Restoring Synaptic Function: How Intranasal Delivery of 3D-Cultured hUSSC Exosomes Improve Learning and Memory Deficits in Alzheimer's Disease.Mol Neurobiol. 2024 Jun;61(6):3724-3741. doi: 10.1007/s12035-023-03733-w. Epub 2023 Nov 27. Mol Neurobiol. 2024. PMID: 38010560
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical